|
|
|
MIRA INFORM REPORT
|
Report No. : |
490752 |
|
Report Date : |
08.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
MEDICINE CENTRE |
|
|
|
|
Registered
Office : |
Shop No. 3, Permanent Shopping Complex, Sector-5, Balco Nagar,
Korba-495684, Chhattisgarh |
|
Mobile No.: |
91-9300263340 (Mr. Parmanand Agrawal) |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Year of
Establishment : |
April 2015 |
|
|
|
|
Capital
Investment : |
INR 8.077 Million (As on 31.03.2016) |
|
|
|
|
IEC No.: |
6313002121 |
|
|
|
|
TIN No.: |
22105200291 |
|
|
|
|
GST No.: |
22AFNPA7965G2ZD |
|
|
|
|
PAN No.: [Permanent Account No.] |
AFNPA7965G |
|
|
|
|
Legal Form : |
Sole Proprietary Concern |
|
|
|
|
Line of Business
: |
Exporter,
Wholesaler, Distributor and Supplier of Pharmaceutical Medicine, Tablet,
Capsule, Syrup, Anti-cancer Medicine, Pharmaceutical Tablet, etc. [Confirmed by management] |
|
|
|
|
No. of Employees
: |
15 [Approximately] |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 23000 [INR 1478555.00] |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject
was established in the year 2015 as proprietorship firm and it is having
satisfactory track records. It is an
exporter, wholesaler, distributor and supplier of pharmaceutical medicine,
tablets, capsule, syrup anticancer medicine, etc. Mr.
Parmanand Agrawal (Proprietor) has provided general information and revenue
figure for the (FY 2016-17 as INR 400 million). However financials could not
be verified from any sources. As per
available data base records of 2016, we could find that firm has achieved
decent revenue from its operation and reported average profitability margin
of 1.44%. Rating
takes into consideration firm’s sound financial profile marked by adequate
capital base along with low debt balance sheet. Further,
rating strength is partially offset by short track records of business
operation and intensely competitive nature of the industry. Trade
relations are reported as fair. Business is active. Payments are seems to be
usually correct. The firm can be considered for business dealings at usual trade terms and condition. NOTE 1: Mr. Parmanand (Proprietor) has claimed that “Medicine Centre” was established in the year 1992 as a branch of “Medicine Corner” which is a proprietorship firm and proprietor is Mr. Divyanand.
In April 2015, Medicine Centre became as a separate entity i.e. proprietorship firm and the proprietor is Mr. Parmanand. NOTE 2: Site visit was conducted at the address which you have provided. Our executive has successfully traced the firm on the given address. At the premises our executive met to Mr. Parmanand Agrawal (Proprietor) of the firm and he provided contact details i.e. 9300263340. As per our executive observation, location of the firm is easy to find. Landmark was Ayushman Hospital. It is 1 storey building and whole premises belong to the firm. Locality appears to be residential. Area seems to be neutral. Area of the premises was 500 (SQ.FT) 10 employees were sighted into premises. Name board of the firm was sighted at the given address. Further, our executive also enquired from neighbours i.e. Mr. Jogendar (Jogendra Shoes Palace) and Mr. Jagdish (Jagdish General Store) and they were also confirmed that firm exists on given address. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 08.02.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION PARTED BY
|
Name : |
Mr. Parmanand Agrawal |
|
Designation : |
Proprietor |
|
Contact No.: |
91-9300263340 |
|
Date : |
07.02.2018 |
LOCATIONS
|
Registered Office : |
Shop No. 3, Permanent Shopping Complex, Sector-5, Balco Nagar, Korba-495684,
Chhattisgarh, India |
|
Tel. No.: |
Not Available |
|
Mobile No.: |
91-9300263340 (Mr. Parmanand Agrawal) |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Area: |
500 [Sq. Ft.] [As per Site Visit] |
|
Location : |
Owned |
|
Locality : |
Commercial |
SOLE PROPRIETOR
|
Name : |
Mr. Parmanand Agrawal |
|
Designation : |
Proprietor |
|
Date of Birth/Age : |
43 Years |
|
Qualification : |
B Tech Pharmacy |
|
PAN No.: |
AFNPA7965G |
BUSINESS DETAILS
|
Line of Business : |
Exporter,
Wholesaler, Distributor and Supplier of Pharmaceutical Medicine, Tablet,
Capsule, Syrup, Anti-cancer Medicine, Pharmaceutical Tablet, etc. [Confirmed
by management] |
|
|
|
|
Products/ Services : |
·
Pharmaceutical Medicine ·
Tablet ·
Capsule ·
Syrup ·
Anti-cancer Medicine ·
Pharmaceutical Tablet, etc. |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
· Roche Products India Private Limited · Abbott India Limited · Unichem Laboratories Limited |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical
Medicine, Tablet, Capsule, Syrup, Anticancer Medicine, Pharmaceutical Tablet,
etc. |
|
Countries : |
· Dubai · Sri Lanka · Vietnam · China · Hong Kong |
|
|
|
|
Imports : |
Not Available |
|
|
|
|
Terms : |
|
|
Selling : |
Advance Payment, Cheque and Credit [30 Days] |
|
|
|
|
Purchasing : |
Advance Payment, Cheque and Credit [30 Days] |
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
End Users and OEMs
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
15 [Approximately] |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
|
|
|
|
Auditors : |
|
|
Name : |
V.A and Associates Chartered Accountants |
|
Address : |
12/B, 1st Floor, Vaishali Complex, Deendayal Square,
Shrikant Verma Marg, Bilaspur, Chhattisgarh,
India |
|
Tel No.: |
91-7752-419016 |
|
Fax No.: |
91-7752-220937 |
|
Email: |
|
|
Membership No: |
401781 |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associates/Subsidiaries : |
Not Available |
CAPITAL STRUCTURE
AS ON 31.03.2016
|
Particulars |
Amount (INR in million) |
|
|
|
|
Opening Balance (01.04.2015) |
5.688 |
|
Add: Net Profit for the year |
4.668 |
|
Total |
10.356 |
|
|
|
|
Less: Withdrawal from Firm |
0.316 |
|
TDS (2015-2016) |
0.077 |
|
Self-Assessment Tax |
0.686 |
|
Advance Tax |
1.200 |
|
|
2.279 |
|
|
|
|
Total |
8.077 |
FINANCIAL ANALYSIS
[all figures are
in INR Million]
|
PARTICULARS |
|
|
31.03.2017 |
|
Sales Turnover (Approximately) |
|
|
400.000 |
|
|
|
|
[Due to more
order] |
The above information has been parted by Mr. Parmanand Agrawal
(Proprietor)
Note : Sole Proprietary and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry Records.
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
|
|
31.03.2016 |
|
|
EQUITY
AND LIABILITIES |
|
|
|
|
|
1] Proprietor’s Capital |
|
|
8.077 |
|
|
2] Reserves & Surplus |
|
|
0.000 |
|
|
NETWORTH |
|
|
8.077 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
0.000 |
|
|
2] Unsecured Loans |
|
|
5.693 |
|
|
TOTAL BORROWING |
|
|
5.693 |
|
|
DEFERRED TAX LIABILITIES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
13.770 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
0.086 |
|
|
Capital work-in-progress |
|
|
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
0.500 |
|
|
DEFERRED TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
4.160 |
|
|
Sundry Debtors |
|
|
6.282 |
|
|
Cash & Bank Balances |
|
|
23.679 |
|
|
Other Current Assets |
|
|
2.002 |
|
|
Loans / Advances and Deposits |
|
|
1.991 |
|
Total
Current Assets |
|
|
38.114 |
|
|
Less :
CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
24.214 |
|
|
Other Current Liabilities |
|
|
0.000 |
|
|
Provisions |
|
|
0.716 |
|
Total
Current Liabilities |
|
|
24.930 |
|
|
Net Current Assets |
|
|
13.184
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
13.770 |
|
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
|
|
31.03.2016 |
|
|
SALES |
|
|
|
|
|
Sales |
|
|
323.197 |
|
|
Other Income |
|
|
0.866 |
|
|
TOTAL |
|
|
324.063 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
|
|
316.592 |
|
|
Freight Expenses |
|
|
0.029 |
|
|
Accounting Expenses |
|
|
0.051 |
|
|
Audit Fees |
|
|
0.029 |
|
|
Bank commission |
|
|
0.079 |
|
|
Courier and Postage
Expenses |
|
|
0.035 |
|
|
Electricity Expenses |
|
|
0.035 |
|
|
Electric Charge Corner |
|
|
0.012 |
|
|
Salary Expenses |
|
|
0.420 |
|
|
Shop Expenses |
|
|
0.028 |
|
|
Vehicle Fuel Expenses |
|
|
0.021 |
|
|
Stationery and Printing |
|
|
0.017 |
|
|
Legal Fees Expenses |
|
|
0.005 |
|
|
Vat Tax |
|
|
1.355 |
|
|
Telephone Expenses |
|
|
0.055 |
|
|
Commercial Tax |
|
|
0.000 |
|
|
Entry tax |
|
|
0.000 |
|
|
Tender Expenses |
|
|
0.000 |
|
|
TOTAL |
|
|
318.763 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE INTEREST AND DEPRECIATION AND
AMORTISATION |
|
|
5.300 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
|
|
0.617 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE DEPRECIATION
AND AMORTISATION |
|
|
4.683 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
|
0.015 |
|
|
|
|
|
|
|
|
NET PROFIT/ (LOSS) |
|
|
4.668 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
|
|
31.03.2016 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
|
|
7.09 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
|
|
51.45 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
|
|
27.92 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
|
|
1.27 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
|
|
61.63 |
LEVERAGE RATIOS
|
PARTICULARS |
|
|
31.03.2016 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total Assets) |
|
|
0.79 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
|
|
0.70 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
|
|
3.79 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
|
|
0.01 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
|
|
8.59 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
|
|
31.03.2016 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
|
|
1.44 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
|
|
12.06 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
|
|
57.79 |
SOLVENCY RATIOS
|
PARTICULARS |
|
|
31.03.2016 |
|
Current Ratio (Current Assets / Current Liabilities) |
|
|
1.26 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
|
|
1.13 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
|
|
0.21 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
|
|
0.70 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
|
|
1.26 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2016 |
31.03.2017 |
|
|
INR In Million |
INR In Million |
|
Sales |
323.197 |
400.000 |
|
|
23.764 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
Yes |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
Yes |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
No |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
No |
|
22 |
Conduct of the banking account |
Yes |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last two years |
Yes |
|
27 |
Reasons for variation <> 20% |
Yes |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last one year |
Yes |
|
30 |
Major shareholders, if available |
No |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
OBSERVATION POINTS
|
Name of Company : |
MEDICINE CENTRE |
|
|
|
|
Address : |
Shop No. 3, Permanent Shopping Complex, Sector-5, Balco Nagar,
Korba-495684, Chhattisgarh, India |
|
Contact No.: |
91-9300263340 |
|
|
|
|
Person to whom we met: |
Mr. Parmanand Agrawal [Proprietor] |
|
|
|
|
Name Board : |
Sighted |
|
|
|
|
Location: |
Easy |
|
|
|
|
Landmark (If Any): |
Near Ayushman Hospital |
|
|
|
|
Total Floors of the Building : |
Ground + 1 Floor |
|
|
|
|
Subject situated on: |
Whole Premises |
|
|
|
|
Locality: |
Commercial |
|
|
|
|
Area of Premises : |
500 [Sq. Ft.] |
|
|
|
|
Area : |
Neutral |
|
|
|
|
No. of employees seen at premises: |
10 [Approximately] |
|
|
|
|
Visibility of
Items: |
·
Telephone ·
Fax Machine ·
Computers ·
Air Conditioner ·
Office Equipment |
|
|
|
|
Neighbours Interview : |
Our executive also enquired from neighbours i.e. Mr.
Jogendar (Jogendra Shoes Palace) and Mr. Jagdish (Jagdish General Store) and
they were also confirmed that firm exists on given address. |
|
|
|
|
Proof of visit: |
Photos |
UNSECURED LOANS
|
PARTICULARS |
31.03.2016 (INR
in Million) |
|
Divyanand Agrawal HUF |
0.180 |
|
Parmanand Agrawal |
1.492 |
|
Parmanand Agrawal HUF |
0.348 |
|
Shankar Lal Agrawal |
0.668 |
|
Shankar Lal Agrawal HUF |
0.357 |
|
Gayatri DeviAgrawal |
0.575 |
|
Rekha Agrawal |
0.561 |
|
Renu Agrawal |
0.204 |
|
Sangeeta Agrawal |
0.893 |
|
Usha Devi Agrawal |
0.415 |
|
|
|
|
Total |
5.693 |
FIXED ASSETS
· Furniture
· Computer System
· Air Conditioner
· TVS Vehicle
· HP Printer
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any
of its beneficial owners, controlling shareholders or senior officers as
terrorist or terrorist organization or whom notice had been received that all
financial transactions involving their assets have been blocked or convicted,
found guilty or against whom a judgement or order had been entered in a
proceedings for violating money-laundering, anti-corruption or bribery or
international economic or anti-terrorism sanction laws or whose assets were
seized, blocked, frozen or ordered forfeited for violation of money laundering
or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the
property or assets of the subject are derived from criminal conduct or a
prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 64.14 |
|
|
1 |
INR 89.50 |
|
Euro |
1 |
INR 79.43 |
INFORMATION DETAILS
|
Information
Gathered by : |
SUP |
|
|
|
|
Analysis Done by
: |
PRS |
|
|
|
|
Report Prepared
by : |
RUP |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as
a reference to assess SC’s credit risk and to set the amount of credit to be
extended. It is calculated from a composite of weighted scores obtained from
each of the major sections of this report. The assessed factors are as follows:
·
Financial condition covering various ratios
·
Company background and operations size
·
Promoters / Management background
·
Payment record
·
Litigation against the subject
·
Industry scenario / competitor analysis
·
Supplier / Customer / Banker review (wherever
available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.
·